- Home
- Achievement
- Media releases FY2020
Text from here
Media releases FY2020
| No. | Date | Media | Broadcasting channel Newspaper, journal |
Headline, title | Page |
|---|---|---|---|---|---|
| 9/30/2020 | Web | Qlife | Nucleic acid drug "SRN-14/GL2-800", A doctor-initiated Phase I clinical trial for unresectable / metastatic recurrent breast cancer starts | ||
| 9/28/2020 | Web | Iyakutsushinsha | Exhibits at「Innovation Japan 2020 - Online University trade show」iCONM | ||
| 9/27/2020 | TV | BS FUJI | If we could go to a micro world? | ||
| 9/18/2020 | Newspaper | The Science News | Start an investigator-initiated Phase I clinical trials (FIRST IN HUMAN) of nucleic acid drug candidate targeting PRDM14 against breast cancer patients | ||
| 9/15/2020 | Web | Asahi Shimbun DIGITAL | Newsletter "KAWASAKI Coastal Area News" Vol.25 published | ||
| 9/15/2020 | Web | Iyaku Keizaisha | Anti-PD-1 Antibody finds a buddy | ||
| 9/11/2020 | Newspaper | The Chemical Daily | Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. | P10 | |
| 9/8/2020 | Newspaper Web |
THE NIKKAN KOGYO SHIMBUN,LTD. | Utilization of “micelle” technology: Possibility for minimally invasive drugs | ||
| 9/7/2020 | Web | CareNet | Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. |
||
| 9/4/2020 | Web | Nikkei Biotechnology & Business | Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. |
||
| 9/3/2020 | Web | QLifePro | Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. | ||
| 9/2/2020 | Web | Oncology Tribune | Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. | ||
| 9/2/2020 | Web | Iyakutsushinsha | Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. |
||
| 9/2/2020 | Web | Nikkei medical | Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. |
||
| 9/2/2020 | Web | The Cancer Institute Hospital | Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. | ||
| 9/2/2020 | Web | Neuro-Central | A peek behind the paper – Sabina Quader and Rosalía Rodríguez-Rodríguez on nanomedicines for neuron targeting | ||
| 8/21/2020 | Newspaper | The Science News | Effective in combination with immune checkpoint inhibitor and nano-DDS | P.4 | |
| 8/19/2020 | Magazine Web |
Advanced Healthcare Materials | mRNA Delivery: Polymeric Nanocarriers with Controlled Chain Flexibility Boost mRNA Delivery In Vivo through Enhanced Structural Fastening | ||
| 8/19/2020 | Web | Nikkei beyond Health | The effect of cancer immunotherapy provides a dramatic improvement with Nanomachines | ||
| 8/14/2020 | Newspaper Web |
MYTTLINE | 【Countermeasure for coronavirus】Catch a right information in a newspaper! Get to know coronavirus ⑥Gene vaccine, expectations and anxiety | ||
| 8/14/2020 | Web | Katei Gahou | A drug with few side effects. Everyone's dream is consistently and gradually realized. | ||
| 8/12/2020 | Newspaper | Koureisya jutaku Shimbun | Progress in brain drug therapy. Effective for Alzheimer's disease. | ||
| 8/11/2020 | Web | ONCOLOGY NEWS | Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma | ||
| 8/11/2020 | Web | Medical Tribune | Realization of chemo-immunotherapy using nano-DDS to dramatically enhances the efficacy of immune checkpoint inhibitors against glioblastoma | ||
| 8/9/2020 | Web | DagoldInfo | Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma | ||
| 8/7/2020 | Web | PHYS ORG | Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma | ||
| 8/7/2020 | Web | 15 MINUTE NEWS | Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma | ||
| 8/7/2020 | Web | SunriseTechno | Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma | ||
| 8/7/2020 | Web | Bright Surf.com | Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma | ||
| 8/7/2020 | Web | nano werk | Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma | ||
| 8/7/2020 | Web | Bioengineer.org | Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma | ||
| 8/7/2020 | Web | Oncolo | Glioblastoma, Pinpoint attack, Utilization of nanocapsules | ||
| 8/7/2020 | Web | Oncology Tribune | Improve effect of chemoimmunotherapy on glioblastoma by Nano micelle dramatically. | ||
| 8/7/2020 | Newspaper | The Chemical Daily | New treatment for malignant brain tumor iCONM Cancer immunity + chemotherapy | P.8 | |
| 8/6/2020 | Web | EurekAlert | Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma | ||
| 8/6/2020 | Web | Nikkei Biotechnology & Business | iCONM, DDS for glioblastoma enhances the therapeutic effect of ICI | P.34 | |
| 8/6/2020 | Newspaper Web |
Nihon Keizai Shimbun | Glioblastoma, Pinpoint attack, Utilization of nanocapsules | P.34 | |
| 7/28/2020 | Web | Burada Biliyorum | #Developing a new strategy to selectively deliver therapies to the brain | ||
| 7/28/2020 | Web | nano THE MAGAZINE FOR SMALL SCIENCE | Developing a new strategy to selectively deliver therapies to the brain | ||
| 7/27/2020 | Newspaper Web |
Yakuji Nippo | Functional advancement of gene therapy drugs-Development of intrahepatic coating agent Innovation Center of NanoMedicine Group | P.3 | |
| 7/27/2020 | Web | PHARM TECH JAPAN ONLINE | Innovation Center of NanoMedicine developed the new method which selectively deliver drugs only to brain tissues. | ||
| 7/27/2020 | Web | Iyakutsushinsha | Develops a new method which selectively delivers drugs only to brain tissues. Expect a creation of centrally acting drug iCONM |
||
| 7/26/2020 | Web | HYS ORG | Developing a new strategy to selectively deliver therapies to the brain | ||
| 7/26/2020 | Web | EurekAlert! | Developing a new strategy to selectively deliver therapies to the brain | ||
| 7/23/2020 | TV | TV Tokyo | Stairs of Quest #42 "Aiming for a panacea with nano medicine" |
||
| 7/20/2020 | Newspaper | The Chunichi Shimbun | "Deeper understanding of Corona!" Development and design at high speed | P.20 | |
| 7/19/2020 | Newspaper | Tokyo Shimbun | "Deeper understanding of Corona!" Development and design at high speed | P.12 | |
| 7/17/2020 | TV | Ruptly TV | Japan: Researchers develop medical Smart Nanomachine that could cure next pandemic | ||
| 7/8/2020 | Newspaper | The Chemical Daily | Improve installation efficiency of gene drugs Innovation Center of NaoMedicine, etc. protect liver with PEG Installation efficiency |
P.12 | |
| 7/7/2020 | Newspaper | Nikkei Sangyo Shimbun | Dementia treatment with nanomachines Efficient drug delivery to brain cells |
P.12 | |
| 7/1/2020 | Web | School of Engineering, The University of Tokyo | Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs Controlling the clearance of gene therapy drugs at the liver sinusoidal wall |
||
| 7/1/2020 | Newspaper Web |
Nikkankogyo Shimubun | Early establishment of new corona/vaccine development technology iCONM and TMIMS conduct collaborative research |
P.25 | |
| 6/30/2020 | Newspaper Web |
Nikkankogyo Shimubun | Colorectal cancer, gene transfer efficiency 10 times, iCONM and others administrate film agents / capsules. | P.26 | |
| 6/29/2020 | Web | National Institutes for Quantum and Radiological Science and Technology | Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs Controlling the clearance of gene therapy drugs at the liver sinusoidal wall |
||
| 6/29/2020 | Web | Nihon no kenkyū.com | Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs Controlling the clearance of gene therapy drugs at the liver sinusoidal wall |
||
| 6/29/2020 | Web | Oncology Tribune | Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs |
||
| 6/27/2020 | Web | BIGLOBE news | Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy Kawasaki Institute of Industrial Promlotion Utokyo | ||
| 6/27/2020 | Web | YAHOO! JAPAN news | Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy Kawasaki Institute of Industrial Promlotion Utokyo | ||
| 6/27/2020 | Web | Jiji Tsushin | Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy Kawasaki Institute of Industrial Promlotion Utokyo | ||
| 6/26/2020 | Newspaper | Science newspaper | Fully synthetic artificial pancreas device, Tokyo Medical and Dental University, Nagoya University, etc. developed | ||
| 6/26/2020 | Web | SSIENMAG | Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy | ||
| 6/26/2020 | Web | Nanotechnology News | Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy | ||
| 6/26/2020 | Web | 7thSpace | Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy | ||
| 6/26/2020 | Web | EurekAlert! | Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy | ||
| 6/18/2020 | Web | Nikkei Beyond Health | Closely watch mRNA drugs for the development of a novel coronavirus vaccine | ||
| 6/17/2020 | Newspaper Web |
Yakuji Nippo | Compound development for control of hepatitis -replace cell growth factor The University of Tokyo/Kawasaki institute of Industrial Promotion Innovation Center of NanoMedicine research group | ||
| 6/12/2020 | Newspaper | Science newspaper | Develop vaccine production technology in preparation for return/reheat of Covid-19 iCONM and Tokyo Metropolitan Institute of Medical Science start collaborative research |
||
| 6/9/2020 | Newspaper Web |
Nikkankogyo Shimubun | Alzheimer's dementia, suppressed by low dose antibody drug iCONM and others succeeded | P.23 | |
| 6/9/2020 | Newspaper Web |
The Chemical Daily | mRNA vaccine, iCONM and TMiMS, develop for corona | ||
| 6/8/2020 | Newspaper Web |
Yakuji Nippo | mRNA vaccine production technology, start collaborative research, Kawasaki institute of Industrial Promotion Innovation Center of NanoMedicine, Tokyo Metropolitan Institute of Medical Science |
P.7 | |
| 6/6/2020 | Web | excite news | iCONM and Tokyo Metropolitan Institute of Medical Science start research on mRNA vaccine for new coronavirus | ||
| 6/6/2020 | Web | goo news | iCONM and Tokyo Metropolitan Institute of Medical Science start research on mRNA vaccine for new coronavirus | ||
| 6/6/2020 | Web | Mynavi news | iCONM and Tokyo Metropolitan Institute of Medical Science start research on mRNA vaccine for new coronavirus | ||
| 6/5/2020 | Web | Yahoo! JAPAN News | Development of RNA vaccination technology for new coronavirus by Kawasaki City Foundation etc. |
||
| 6/5/2020 | Web | Iyakutsushinsha | iCONM and Tokyo Metropolitan Institute of Medical Science start collaborative research of creating technology for the development of mRNA vaccine integrated with an adjuvant function. |
||
| 6/5/2020 | Web | Jiji Tsushin | Development of RNA vaccination technology for new coronavirus by Kawasaki City Foundation etc. |
||
| 6/5/2020 | Web | Nikkei Biotechnology & Business | iCONM and Tokyo Metropolitan Institute of Medical Science to develop mRNA-based vaccine for new corona |
||
| 6/4/2020 | TV | TV KANAGAWA | Collaborative research on inexpensive vaccine production New Corona | ||
| 6/2/2020 | Web | Nikkei Beyond Health | Insurance covers "Medical device x drug 'fifth cancer treatment'" | ||
| 5/29/2020 | Web | Iyakutsushinsha | Current status and prospects of nanomedicine and chemical surgery development by Dr. Nobuhiro Nishiyama (Professor, Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology) | ||
| 5/27/2020 | Web | Nikkei Beyond Health | Development of Nanomachines to deliver anti-dementia drugs to the brain |
||
| 5/22/2020 | Newspaper | The Chemical Daily | Delivering therapeutic antibodies into the brain / Control dementia with a low dose |
||
| 5/1/2020 | Web | BUSINESS INSIDER | Aiming to supply "early mass-produced" domestically produced new coronavirus vaccine within the year. Asked the developer about the latest situation. | ||
| 4/30/2020 | Web | NewsPicks | Development of the Functional Polymers that Recognize Biosignals and the Application for Drug Delivery System | ||
| 4/28/2020 | Web | Deutsche Well | COVID-19: Nanomachines to be deployed to fight next viral pandemic | ||
| 4/8/2020 | Newspaper Web |
The Chemical Daily | mRNA drug: Promising for novel corona virus / Ask Prof. Keiji Itaka, Tokyo Medical and dental University. | ||
| 4/1/2020 | Magazine | Pharm Tech Japan | Challenge of Industry-government-academia for nucleic acid drug creation (6) Development of new polymer-based DDS for practical use: The effort centering on venture companies based on industry-academia collaboration |
P.31-37 | |
| 4/1/2020 | Web | RikeLab | Succeeded in making DNA into a single-stranded and encapsulate in nanomachines! World's first technology opens up new possibilities for gene therapy. Science career pictorial book vol.18 Innovation Center of NanoMedicine Dr. Theofilus A. Tockary |